MoneyWorks4Me

Sai Life Sciences sets up Peptide Research Center in India

04 Apr 2025 Evaluate

Sai Life Sciences has set up a dedicated Peptide Research Center at its integrated R&D Campus in Hyderabad, India. The Peptide Research Center is designed to support innovator pharma and biotech companies with specialized services across peptide synthesis, discovery, and advanced modalities, including complex conjugates. The facility integrates automation, advanced liquid handling, robotics, and high-throughput systems, enhancing precision, scalability, and efficiency in the development of novel peptide-based therapeutics.

The new Peptide Research Center will be integrated with company’s end-to-end discovery services, spanning synthetic and medicinal chemistry, biology, DMPK, and toxicology. This holistic approach ensures seamless transitions across different stages of drug discovery, accelerating timelines and enhancing success rates for peptide-based drug development.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..